endoluminal solutions, Inc. increased its capital from JPY 6.07 million to JPY 48.588 million, effective upon registration on April 28, 2026, in order to support business expansion and strengthen our development capabilities.
We will continue to advance the development and commercialization of our disposable endoscope dedicated to gastric cancer screening and contribute to improving access to healthcare.
We sincerely appreciate your continued support.